ALPN
Alpine Immune Sciences Inc
ALPN
ALPN
Delisted
ALPN was delisted on the 17th of May, 2024.
180 hedge funds and large institutions have $2.56B invested in Alpine Immune Sciences Inc in 2024 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 66 increasing their positions, 42 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
35% more funds holding
Funds holding: 133 → 180 (+47)
47% less call options, than puts
Call options by funds: $6.29M | Put options by funds: $11.8M
Holders
180
Holding in Top 10
11
Calls
$6.29M
Puts
$11.8M
Top Buyers
| 1 | +$229M | |
| 2 | +$78.6M | |
| 3 | +$57.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$55.2M |
| 5 |
DC
Decheng Capital
Menlo Park,
California
|
+$48.9M |
Top Sellers
| 1 | -$102M | |
| 2 | -$93.6M | |
| 3 | -$61.9M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$41.8M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$29.6M |
